HQC Insights

HealthQuest Capital helps Lunit commercialize in the US

9 August 2022
< Back to News

Check out the video below of Garheng Kong describing portfolio company Lunit's differentiated approach to precision diagnostics and therapeutics in oncology.

Speak to us.

 

Contact Us.